Purpose: To determine whether ultra-wide-field fundus autofluorescence (UWFFAF) findings in acute zonal occult outer retinopathy correlated well with perimetry, optical coherence tomography, and electroretinography findings.
A cute zonal occult outer retinopathy (AZOOR) is an idiopathic syndrome characterized by an acute onset of photopsias, scotoma, or both and is typically associated with a persistent loss of function involving one or more zones of the outer retina. [1] [2] [3] AZOOR was first reported by Donald Gass 1 in 1992 when he presented his observations on 13 patients at the Donders Lecture of the Netherlands Ophthalmological Society. AZOOR can involve one or both eyes, and the condition usually stabilizes within 6 months of onset of symptoms although some cases continue to progress. During the acute stage, there may be no ophthalmoscopically detectable fundus abnormality. However, some cases can present with a transient gray-white or white ring encompassing the involved area of retina, a presentation that has been referred to as acute annular outer retinopathy (AAOR). [4] [5] [6] During the chronic stages, the affected areas typically manifest signs of atrophy of the retinal pigment epithelium (RPE) and/or intraretinal pigment migration. 1, 2, 7 The ophthalmic diagnostic tests used in the evaluation and monitoring of patients with AZOOR include perimetry, electroretinography (ERG), optical coherence tomography (OCT), and fundus autofluorescence (FAF). Visual field changes that have been reported in association with AZOOR include enlargement of the blind spot, central scotoma, paracentral scotoma, arcuate scotoma, annular scotoma, altitudinal hemianopia, and constriction of the peripheral field.
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Almost every patient with AZOOR demonstrates some degree of abnormality on full-field ERG (ffERG) and/ or multifocal ERG (mfERG). 2, 9, 11, 12 In addition, abnormalities in electrooculography have been reported in patients with AZOOR. 13 Therefore, the diagnosis of AZOOR should be questioned in the setting of a normal electrophysiological test. The changes seen on OCT within the affected area of the retina in patients with AZOOR include irregularity of the RPE, absence or irregularity of the inner segment/outer segment junction or the ellipsoid zone (EZ), attenuation of the outer nuclear layer (ONL), and decreased overall thickness of the retina. 2, [14] [15] [16] [17] [18] [19] The FAF findings in patients with AZOOR have been described in a limited number of reports. The most common finding on FAF imaging in AZOOR is a zone of hypoautofluorescence surrounded by a border of hyperautofluorescence. 2, 14, [20] [21] [22] The hypoautofluorescence in the central portions of the AZOOR lesion is due to RPE atrophy, whereas the hyperautofluorescence of the border of the lesion is attributed to accumulation of lipofuscin-like material at the edges of the lesion. 22 However, in a few published cases, there was no abnormality detected on FAF imaging. 14, 23 Ultra-wide-field FAF (UWFFAF) is an imaging modality which has become available recently for use in clinical practice that allows imaging of more than 200°or 82% of the retina. 24, 25 Because of the much larger area of retina imaged as compared with standard FAF that images up to 30°of the retina, 26 or wide-field FAF that can image 50°to 60°of the retina, 27 changes that involve the peripheral retina which could be missed by the latter tests are likely to be detected on UWFFAF. Therefore, we examined the question that UWFFAF imaging can correspond to abnormalities found on perimetry, OCT, and ERG in patients with AZOOR, and that there is clinical utility of this test in the initial evaluation and monitoring of progression in patients with AZOOR.
Methods

Study Subjects
New patients diagnosed with AZOOR and seen by the authors at a single referral center during the period from October 2012 to March 2015 who had UWFFAF performed were included in the study. The diagnosis of AZOOR was made on the basis of the presence of photopsias, subjective loss of visual field, or both, in association with one or more contiguous zones of outer retinopathy (as evidenced by changes on perimetry, OCT, or ERG) in the absence of any other identifiable etiology by ophthalmic examination, by electrophysiology or by laboratory testing (including tests for syphilis and tuberculosis). Of the 14 patients who were identified as having a diagnosis of AZOOR, 10 patients (16 eyes) met the criteria for AZOOR diagnosis required for inclusion in this study. The study was approved by the Institutional Review Board of Oregon Health & Science University. The study was also compliant with the Health Insurance Portability and Accountability Act and was conducted in accordance with the tenets of the Declaration of Helsinki. Identifying information was removed from all data, and given the retrospective nature of the study, obtaining informed consent was not required.
Collection of Demographic and Clinical Data
Demographic and clinical data were collected by reviewing the electronic medical records of the study subjects, including age, sex, race, nature and duration of symptoms, the presence of any antecedent illness, best-corrected visual acuity, the presence of relative afferent pupillary defect, the presence of cells in the anterior chamber or in the vitreous, and findings on ophthalmoscopy. Bilateral disease was designated if patients had bilateral symptoms and at least two imaging modalities confirming involvement of both eyes, or if patients had only unilateral symptoms but two imaging modalities confirmed AZOOR-like lesions in the contralateral eye, defined as a contiguous zone or zones of outer retinal and/or RPE changes.
Ophthalmic Imaging and Perimetry
All patients underwent both UWFFAF imaging and pseudocolor (red and green only) imaging using the Optos ultra-wide-field imaging device (Optos, Marlborough, MA). The UWFFAF images were acquired using a scanning laser ophthalmoscope technology with a green laser of 532 nm as the excitation light and with signal emitted from the retina detected from a raster scan after passing through an emission filter with a bandpass of 570 nm to 780 nm. The OCT scans of the retina were obtained with spectral-domain technology (SD-OCT) using the Spectralis system (Heidelberg Engineering, Calsbad, CA). The FAF images were also obtained on the Spectralis system with excitation at 488 nm and with an emission filter with a bandpass of 500 nm to 680 nm. Static and kinetic visual field measurements were obtained with the Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, CA) or the Octopus 900 system (Haag-Streit, Mason, OH) by following the instructions of each manufacturer. An improvement in UWFFAF was defined as a change from hyperautofluorescent to normal autofluorescence, whereas worsening was defined as the development of new hyperautofluorescent or hypoautofluorescent lesions, and a stable UWFFAF was defined as an image that appeared the same in terms of lesion extent and degree of autofluorescence. Lesion spread was also documented based on the proposition by Gass that the inciting agent gains access to the photoreceptors through the disruption in the RPE at the optic nerve and at the ora serrata. 28 Based on this supposition, and the obligatory zonal process of AZOOR, centripetal spread was designated if the lesion appeared to arise in the peripheral retina and then spread posteriorly toward the posterior pole, whereas centrifugal spread was defined as a lesion that appeared to arise near the optic disc or in the macular region and then spread peripherally in a concentric, contiguous pattern. Centripetal + centrifugal spread was designated if both patterns were seen but were noncontiguous (separated by an unaffected zone). Correlation between UWFFAF and perimetry findings was designated if the location of autofluorescence abnormalities anatomically corresponded to the location of the visual field defect (e.g., if there was temporal peripheral hyperautofluorescence, it correlated with perimetry if there was corresponding nasal peripheral perimetric constriction).
Electroretinography
Full-field ERGs were obtained according to a previously described protocol that complied with the standards published by the International Society for Clinical Electrophysiology of Vision (ISCEV). [29] [30] [31] Multifocal ERG testing was performed for each eye separately using the VERIS Multifocal System (Electro-Diagnostic Imaging, Redwood City, CA) with 6.0.3 Science software using a Burian-Allen bipolar contact lens electrode according to the ISCEV guidelines with a protocol that used 103 hexagons, a bandpass from 10 Hz to 300 Hz with the test split into 8 fiftysecond test segments.
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Results
Demographic and Fundus Exam Findings of Acute Zonal Occult Outer Retinopathy Patients
There were a total of 10 subjects and 16 affected eyes included in the study (Table 1) . Of the 16 affected eyes, 14 eyes also had ERGs and perimetry performed at least once. There were three women and seven men. The mean age of the study subjects was 38.3 years (range 14-76) and 50% of the subjects were white. All subjects had a negative syphilis serology, and tuberculosis testing, when available, was negative. None of the subjects had pulmonary findings on chest X-ray to suggest an alternative etiology. Four subjects (40.0%) had bilateral presentation both by symptoms and by findings on imaging, whereas 6 subjects (60.0%) had bilateral presentation based on changes in at least 2 imaging modalities. All bilateral subjects had varying degrees of asymmetry. The duration of symptoms at presentation ranged from 1 week to 8 years ( Table 2 ). All subjects experienced subjective loss of visual field, whereas photopsias were present in seven subjects. Only one case, who presented within one week of the onset of symptoms, reported an antecedent flu-like illness one week before the onset of visual symptoms (Subject 7). The best-corrected visual acuity at presentation ranged from 20/20 to 20/200. Half of the subjects had myopia, whereas the other half had hyperopia or emmetropia ( Table 2 ). Vitreous cells were present in 5 of the 16 (31.3%) eyes. There were pigmentary changes in the fundus (RPE atrophy and/or intraretinal pigment migration) in all the 10 eyes that had symptoms for 6 months or more ( Table 2 ). Eyes that presented acutely had either disk edema and/or outer retinal lesions or no acute lesions visible on fundus examination. One eye (Subject 3, Figure 2 ) that had symptoms for only one week had a wedge-shaped area of RPE atrophy extending from the optic nerve, proximal to newer outer retinal lesions extending into the fovea, but that subject also had an episode of similar self-resolving symptoms in the affected eye 4 years before presentation that may have resulted in the observed RPE atrophy. There was a peripapillary annular outer retinal ring in both eyes of one subject who presented one week after the onset of symptoms (Subject 7) which resolved over time ( Figure 5 , A and B). There were multifocal pinpoint grayish RPE lesions in one subject who presented with acute symptoms (Subject 10, Figure 1 ) which may represent a concomitant multifocal choroiditis without panuveitis.
Ultra-Wide-Field Fundus Autofluorescence Findings and Visual Acuity in Acute Zonal Occult Outer Retinopathy at Presentation
In subjects who presented within 3 months of onset of symptoms, the affected areas exhibited a contiguous zone of hyperautofluorescence on UWFFAF (Subjects 2, 3, 7, and 10, a total of 5 eyes; see Table, Supplemental Digital Content 1, http://links.lww. com/IAE/A524). Subject 7, who presented one week after symptom onset, had multiple spots of hyperautofluorescence in the temporal macula along the temporal boundary of the affected diffusely hyperautofluorescent zone ( Figure 5 ). In Subject 3, who presented within one week of onset of symptoms but was also symptomatic 4 years earlier, the FAF showed a peripapillary wedge of hypoautofluorescence adjoined by a diffuse ring of hyperautofluorescence with pinpoint hyperautofluorescent dots at the edges of the affected area ( Figure 2 ). It should be noted that 1 week after symptom onset in the right eye in Subject 3, the left eye subsequently became symptomatic and developed a hyperautofluorescent area in the periphery. In all other subjects, who had symptoms that lasted for 6 months or more, the typical appearance on UWFFAF was a zone of hypoautofluorescence surrounded by a ring of hyperautofluorescence. The zones of hypoautofluorescence were uniform in some of these cases, but were patchy or mottled in the remaining cases. The ring of hyperautofluorescence bordering the hypoautofluorescent zone in chronic subjects was more intensely hyperautofluorescent than the hyperautofluorescence noted in acute cases. In 14 of the 16 eyes, the peripapillary area and/or the macula were affected on UWFFAF. In 4 of the 10 subjects, satellite lesions noncontiguous with the main lesion were seen (Subjects 3, 7, 8, and 10).
Among the 16 eyes included in the study, 2 main patterns of spread of AZOOR were identified based on the appearance on UWFFAF: centrifugal spread (7/16 eyes or 43.8%) (Figures 2 and 3 ) and centripetal spread (5/16 eyes or 31.3%) ( Figure 1 ) (Table 1 and  see Table, Supplemental Digital Content 1, http:// links.lww.com/IAE/A524). The remaining 4 of the 16 eyes (25.0%) had evidence of both centrifugal and centripetal spread. Definitions of these designations of lesion spread are specified in the Methods section. In 2 subjects (Subjects 3 and 6), spread was centripetal in one eye and both centripetal and centrifugal in their contralateral eyes.
Among the 7 eyes with a centrifugal pattern of AZOOR, both eyes of Subject 7 showed an annular ring of hyperautofluorescence centered on the optic disc ( Figure 5 , right eye shown), and Subject 5 showed a concentric ring of hyperautofluorescence more or less centered on the fovea but also encompassing the optic nerve ( Figure 3 ). In Subject 7, who presented acutely, UWFFAF showed uniform hyperautofluorescence in the area enclosed within the annular ring and small spots of hyperautofluorescence at the temporal border ( Figure 5C ). This case was similar to reported cases of a likely subset of AZOOR termed AAOR by Gass. 4 This subject presented to us one week after the onset of visual symptoms which began 1 week after a flu-like illness. Laboratory testing showed IgG but no IgM antibodies in the serum against cytomegalovirus and Epstein-Barr virus, and no antibodies were found against herpes simplex, varicella zoster, hepatitis B, hepatitis C, and human immunodeficiency viruses. One patient (Subject 8) had bilateral AZOOR with centrifugal + centripetal spread in both eyes (Figure 4 , left eye shown). Ophthalmoscopy in this patient revealed chorioretinal atrophy inferiorly in the macula and bone spicules in the periphery. The UWFFAF showed a zone of hypoautofluorescence in the macula with an outer border of hyperautofluorescence (centrifugal spread) and a zone of nasal hypoautofluorescence with an inner border of hyperautofluorescence in the peripheral retina extending in a circumferential manner (centripetal spread) ( Figure 4B ). In this case, the peripheral involvement would have been missed on a 50°field FAF centered on the fovea. The UWFFAF was able to reveal the full extent of the AZOOR lesions in 11 of the 16 eyes (68.8%) which may have been missed if a 50°field FAF centered on the fovea had been performed instead. Although mean logMAR converted best-corrected visual acuity was slightly higher (worse) in eyes with centrifugal spread (0.3) than eyes with centripetal spread (0.1) on UWFFAF, this was not statistically significant (Table  1) , likely because of the small sample size.
Perimetric Findings in Acute Zonal Occult Outer Retinopathy
All 14 eyes that had perimetry performed showed visual field changes that corresponded well to areas of UWFFAF abnormalities (see Table, Supplemental Digital Content 1, http://links.lww.com/IAE/A524) except for Subject 2 in which the extent of visual field loss appeared larger than the extent of UWFFAF changes likely because of the optic nerve itself being inflamed on presentation in addition to the peripapillary outer retina. For instance, in Subject 7, the C-shaped ( Figure 5C ) or reverse C-shaped areas of hyperautofluorescence on UWFFAF were analogous to the reverse C-shaped ( Figure 5K ) or C-shaped scotomas seen on perimetry. The visual field changes were variable depending on the presentation and UWFFAF findings, consisting of enlarged blind spots, superior altitudinal scotoma, inferior arcuate defects mimicking glaucoma, cecocentral scotomas, and peripheral isopter constrictions (see Table, Supplemental Digital Content 1, http://links.lww.com/IAE/A524).
Optical Coherence Tomographic Findings in Acute Zonal Occult Outer Retinopathy
All 16 eyes had macular OCTs performed, and if the macula was involved on UWFFAF, this corresponded to areas of EZ and external limiting membrane (ELM) loss (see Table, Supplemental Digital Content 1, http://links.lww.com/IAE/A524) in acutely presenting cases. During acute presentation in Subject 7, there was parafoveal hyperreflectivity of the ONL in the transition area between the affected and unaffected retina (in the area of the yellowish/grayish outer retinal ring on fundus examination) which appears to resolve over time once this ring is no longer visible on fundus imaging or fundus examination (Figure 5, F and G) . The other subjects, who presented 6 months or more from the onset of symptoms, had varying degrees of EZ and ELM loss in the macula also accompanied by ONL loss with or without underlying RPE atrophy. In subjects in whom RPE atrophy had occurred, there was always overlying EZ, ELM, and ONL loss. Choroidal atrophy was not common, occurring in only two subjects, one of whom was elderly at the age of 76 (Subject 6), and another was aged 59, but a moderate myope (Subject 8).
Electroretinography Findings in Acute Zonal Occult Outer Retinopathy
Eleven eyes of 6 subjects underwent both ffERG and mfERG, whereas 1 subject (Subject 3, both eyes) Spectral domain optical coherence tomography at 20 months shows normalization of EZ and ELM disruptions outside the area of RPE atrophy. E. Ultra-wide-field fundus autofluorescence shows both centrifugal spread of the hyperautofluorescent lesions and centripetal spread from the temporal periphery (white arrows), which resolve on follow-up UWFFAF (F). Refer to Table 3 for associated perimetric findings. White dotted arrows designate the pattern of spread of AZOOR (centripetal vs. centrifgual).
underwent only ffERG, and 1 subject (Subject 2, left eye only) underwent only mfERG. On ffERG, the roddriven responses (dark-adapted 0.01 stimulus) were both subnormal in amplitude and prolonged in timing in 7 of the 13 eyes (53.8%) tested (see Table, Supplemental Digital Content 1, http://links.lww.com/IAE/A525). The amplitude of the a wave in response to the darkadapted 3.0 stimulus was subnormal in 9 of the 13 eyes (69.2%). Cone-driven responses were subnormal in amplitude, prolonged in timing or both in 8 of the 13 Fundus image of the right eye showing retinal pigment epithelial cell mottling and outer retinal ring surrounding the macula. B. UWFFAF demonstrates mottled macular hypoautofluorescence with ring of hyperautofluorescence surrounding the macula. Far temporal scalloped hypoautofluorescence with a posterior hyperautofluorescent border likely represents the ora serrata rather than pathological changes. C. Full-field ERG findings (see Table 4 for details). D. Multifocal ERG findings from the right eye demonstrating decreased amplitudes and timing centrally greater than in the peripheral macula. E. Kinetic perimetry reveals dense cecocentral scotoma and optical coherence tomography (F) reveals ellipsoid zone, external limiting membrane, and outer nuclear layer loss throughout the macula including the foveal area. eyes (61.5%). The photopic 30 Hz flicker was subnormal in amplitude, prolonged in timing or both in 9 of the 13 eyes (69.2%). Not surprisingly, the 5 eyes that had purely centrifugal spread had less abnormalities on their ffERG compared with eyes that had centripetal spread or centripetal + centrifugal spread on UWFFAF.
In the 11 eyes tested successfully, mfERG demonstrated reduced amplitudes and prolonged implicit times ( Table 3 ). The specific areas that showed subnormal responses on mfERG corresponded well with the macular areas that showed changes on UWFFAF and outer retinal/RPE changes on OCT. There was good correlation between location of mfERG abnormalities and perimetric findings, too. In the eyes with purely centrifugal spread, mfERG was more likely to affect only part of the tested field (six of the six eyes) compared with those with other patterns of spread, which were more likely to have diffuse involvement on the mfERG rather than partial involvement (1 of the five eyes had partial involvement) (P = 0.006).
Utility of Ultra-Wide-Field Fundus Autofluorescence in Monitoring the Progression of Acute Zonal Occult Outer Retinopathy
Nine of the 10 subjects (14 eyes) had some degree of follow-up ranging from 1 month to 29 months with repeat UWFFAF imaging at last follow-up. In 4 of these subjects (Subjects 2, 3, 4, and 7), there was an improvement in symptoms and/or UWFFAF findings (Table 4) . Three of the 4 of these patients were given oral prednisone alone, and 1 subject (Subject 7) was given oral prednisone plus an oral antiviral agent. Subject 4 had a clear improvement in symptoms while on prednisone which seemed to recur on steroid taper, but was later able to taper off steroids completely without recurrence in symptoms. Because Subject 4 did not present acutely with symptoms but rather with worsening of baseline photopsias, his UWFFAF findings were chronic to begin with (hypoautofluorescent lesion with hyperautofluorescent border), and did not change on treatment although there was symptomatic improvement. Subject 10 was treated with oral prednisone at 1-month follow-up because of worsening of symptoms and UWFFAF findings and after a negative infectious workup, but was then lost to follow-up. Subject 7, (whose right eye is demonstrated in Figure  5 ), presented acutely after a viral prodrome. Although the total area of hyperautofluorescence seemed to enlarge initially between his first UWFFAF image and his 2-week UWFFAF image, for the first week he had not yet received treatment and was later started on valacyclovir for 1 week followed by initiation of oral prednisone 1 mg/kg by his treating physician.
Treatment with the combined regimen seemed to lessen symptoms, decrease the overall area of hyperautofluorescence from the 2-week visit, as well as improve foveal EZ reflectivity on OCT ( Figure 5 , F-H), although with residual parafoveal defects. Subjects who were not treated had no change in UWFFAF findings (except for the above-mentioned subject 10 who worsened on UWFFAF and by symptoms in the 1 month before treatment initiation) and seemed to be stable symptomatically except for Subject 1, who seemed to have worsening scotomas in the right eye despite a stable UWFFAF, and treatment of his cystoid macular edema with dorzolamide and bromfenac. Overall, stability in UWFFAF findings seemed to correspond to stability in OCT findings and stability in symptoms. However, improvements in UWFFAF seemed to correspond to improvements in OCT (Figures 2 and 5 ) and improvement in symptoms (Table 4 ). In 3 eyes of 2 different patients (Subjects 2 and 3), there was return to a normal FAF in once-hyperautofluorescent areas on follow-up. 
Discussion
Our study demonstrated UWFFAF abnormalities in all AZOOR subjects and, in addition, demonstrated a high degree of correlation between UWFFAF findings and perimetry and either ffERG or mfERG depending on the zone of retina involved. We also demonstrated good correlation between UWFFAF macular abnormalities (which can also be demonstrated by standard or 50°FAF) and SD-OCT findings. Acute findings seem to differ from chronic findings in AZOOR: acute disease presents with diffuse hyperautofluorescence on UWFFAF that corresponds to EZ and ELM disruption (without ONL or RPE disruption) on OCT, both of which can improve or resolve over time; chronic findings comprised either mottled or diffuse hypoautofluorescence with a hyperautofluorescent border, and correspond to EZ, ELM, and ONL disruption often with some degree of underlying RPE atrophy. Contiguous zones of involvement were classified into distinct patterns, centrifugal (spreading outward from the optic nerve) versus centripetal (spreading inward from the ora serrata), or both, and was unlikely to involve the midperipheral retina by itself. One plausible explanation for these contiguous zones of involvement of the retina in AZOOR is cell-to-cell spread of an infectious agent involving the photoreceptors followed by a delayed immune response as proposed by Gass.
1 According to Gass's hypothesis, AZOOR occurs in these contiguous zones, which we have described as centrifugal versus centripetal spread, because the inciting agent may gain access to the neurosensory retina through areas where it is not as well isolated from the systemic circulation by the RPE (at the optic nerve and the ora serrata). 28 In patients with centripetal + centrifugal spread, it is possible that the putative etiologic agent gains access to the neurosensory retina both at the optic disc and at the ora serrata because the central and peripheral zones of involvement can exist simultaneously without an overlap between the two zones. Centripetal and centrifugal patterns of distribution have also been recently reported by Tan et al. 34 Whether or not the pattern of spread of lesions has a bearing on visual acuity outcomes is unknown because we did not have high enough power to establish a statistically significant difference although we found a trend toward worse visual acuity in subjects with a centrifugal spread.
Although this study maintained a relatively strict clinical definition for AZOOR, the trizonal pattern described by Mrejen et al 35 to be pathognomonic for AZOOR was not present uniformly in our cohort.
They astutely describe the trizonal pattern of AZOOR on FAF to include a normal zone of autofluorescence (Zone 1), a speckled hyperautofluorescent zone (Zone 2), and a hypoautofluorescent zone (Zone 3) thought to be associated with choroidal atrophy. Analogous zones were also described by this group on SD-OCT. Although Zones 1 and 2 were seen in all of our AZOOR patients, acutely presenting patients did not have Zone 3, nor was choroidal atrophy a prevalent finding in our entire cohort outside age-related or myopic thinning. Chronically symptomatic patients in our cohort did meet trizonal criteria on autofluorescence but did not meet trizonal criteria on SD-OCT for the latter reason. Indeed, Mrejen et al 35 recognize that three patients in their large series did not show a trizonal pattern but rather showed diffuse hyperautofluorescence, similar to the presentation of our acutely presenting patients. We propose that acute presentation of AZOOR to a referral clinic is rare given its often insidious nature and tendency for initial misdiagnosis, and that acutely presenting AZOOR patients will have diffuse hyperautofluorescence rather than a trizonal appearance unless they have an acute on chronic presentation. Also, unlike the above-mentioned study, our investigators did not perform indocyanine green angiography on our patients. Furthermore, although progression is a hallmark of AZOOR, this was seen variably in our cohort. This is likely due to the fact that acutely presenting patients were usually treated, and this was potentially associated with regression, whereas the acutely presenting patients who were not treated right away did in fact show initial progression. Our chronically presenting patients, however, had such long-standing disease that they did not show progression during the relatively short follow-up period, likely because of stabilization of disease before presentation to our practice.
The exact mechanism of hyperautofluorescence in acutely affected areas of the retina is not entirely clear. It is possible for instance, that this is due to photoreceptor outer segment inflammation resulting in loss of photopigment, and a subsequent relative increase in emission of autofluorescence from the underlying RPE. The subjects who demonstrated return to normal autofluorescence seem to support this hypothesis rather than a primary RPE process for hyperautofluorescence, especially given the relatively low-intensity hyperautofluorescence this acute process produces. Alternatively, increased production of autofluorophores from inflamed photoreceptor outer segments or infiltrating leukocytes could potentially contribute to the above finding. Finally, we cannot rule out that the increased lipofuscin accumulation in abnormal RPE is not progressing toward normal autofluorescence as it transitions toward atrophy before exhibiting hypoautofluorescence. Regarding the mechanism of hyperautofluorescence at the border of hypoautofluorescent lesions in chronic patients, this is likely due to increased production and/or decreased clearance of lipofuscin by the RPE 36 given its persistent nature and increased intensity of hyperautofluorescence compared with acute patients. Hypoautofluorescent areas in our chronic patients were generally thought to be due to RPE atrophy, although the RPE layer was at times not as thin as expected on OCT for the degree of hypoautofluorescence, perhaps due to compensatory pigment hyperplasia. It is not clear if the RPE involvement in AZOOR is part of the primary pathology or if it occurs in a secondary manner following involvement of the outer neurosensory retina.
It is also not clear whether or not the hyperautofluorescent border surrounding the hypoautofluorescent zone indicates the presence of disease activity in AZOOR. In fact, the development of a hyperautofluorescent border may be a secondary sign of disease resolution and stabilization, as demonstrated in Subject 7. In a retrospective study performed by Fujiwara et al 14 involving 19 eyes of 11 patients, FAF abnormalities were seen in 17 of the 19 eyes. In that study, there was progression of the affected area on FAF after a mean follow-up of 69.7 months. Although our study used UWFFAF instead of standard FAF, and we had a shorter mean follow-up of 12.7 months, in this period, we did not see progression in patients who presented with chronic symptoms. We did see temporary worsening in two patients who presented acutely, but this was reversed with treatment, lending some degree of credence to a possible benefit of treatment over observation in acutely presenting patients. The UWFFAF seemed to be useful in capturing more extensive involvement than standard or even regular wide-field FAF in 69% of eyes. The UWFFAF also demonstrated imaging improvements in acute patients all of whom were treated with oral prednisone, which correlated to SD-OCT improvements and symptomatic improvement. The long-term progression or stability of these patients compared with untreated patients remains to be determined. It should also be noted that whether the acute UWFFAF lesions (also seen on SD-OCT) would have improved spontaneously without treatment remains a possibility that could not be established in this study.
The study subject who presented with an AAOR type AZOOR deserves special attention. Acute annular outer retinopathy was first reported by Gass and Stern 4 in 1995 in a 23-year-old man who had a sudden onset of progressive scotoma in one eye. In that patient, the annular ring was located in the superotemporal quadrant of the affected eye. The ring subsided within 4 weeks after the onset of symptoms, and within a year after presentation, the patient developed depigmentation of the RPE within the affected area followed by pigment migration into the retina. Subsequently, Fekrat et al 5 reported four patients with AAOR two of whom later developed fundus changes that varied from mild RPE atrophy to marked atrophy with subretinal fibrosis. In our patient with AAOR, there was OCT ONL hyperreflectivity precisely at the location of this annular ring, which resolved on its own before initiation of treatment (2 weeks after presentation but 3 weeks after symptom onset). We believe that the appearance of the ring on examination is due to this change in the photoreceptor nuclei, but it is unclear whether this represents a different process than other types of AZOOR, or if it is missed in other AZOOR cases based on timing of presentation.
The strengths of this study include the relative rigor with which an AZOOR diagnosis was defined, the use of UWFFAF and OCT in all cases at both presentation and follow-up, and the high proportion of patients who had concomitant perimetry and ERG for comparison. The weaknesses of this study include its size, follow-up period, and retrospective nature, including slightly differing scan protocols and an inconsistent set of multimodal imaging ordered by the various contributing clinicians. Despite the above weaknesses, cross-sectional information could be drawn at the initial time point on the correlation of UWFFAF findings to other imaging modalities, including functional studies such as ERG and perimetry. Although ERG changes seen in this cohort were not specific to AZOOR as a disease entity, they were important in establishing functional correlates to UWFFAF findings (along with visual fields). Furthermore, followup UWFFAF imaging in AZOOR patients provided important information in terms of regression or stability of lesions, and corresponded well to SD-OCT findings at follow-up. Therefore, we can conclude that UWFFAF, especially in conjunction with SD-OCT, both of which have the benefit of being quicker and more easily obtained than perimetry and ERG, is a useful imaging tool in the initial evaluation and monitoring of AZOOR patients.
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